| Original language | English |
|---|---|
| Journal | British Journal of Clinical Pharmacology |
| Volume | 85 |
| Issue number | 4 |
| Pages (from-to) | 859-860 |
| Number of pages | 2 |
| ISSN | 0306-5251 |
| DOIs | |
| Publication status | Published - Apr 2019 |
| MoE publication type | B1 Journal article |
Fields of Science
- HUMAN UDP-GLUCURONOSYLTRANSFERASES
- CODEINE
- 317 Pharmacy
Cite this
@article{a24ae9b86ed54fac892ea2b2be4aaf8e,
title = "Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?",
keywords = "HUMAN UDP-GLUCURONOSYLTRANSFERASES, CODEINE, 317 Pharmacy",
author = "Moshe Finel and Erkka J{\"a}rvinen",
year = "2019",
month = "4",
doi = "10.1111/bcp.13868",
language = "English",
volume = "85",
pages = "859--860",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley",
number = "4",
}
Case report by Toce and co-authors : Have all the reasons for poor morphine glucuronidation been addressed? / Finel, Moshe; Järvinen, Erkka.
In: British Journal of Clinical Pharmacology, Vol. 85, No. 4, 04.2019, p. 859-860.Research output: Contribution to journal › Letter › Scientific
TY - JOUR
T1 - Case report by Toce and co-authors
T2 - Have all the reasons for poor morphine glucuronidation been addressed?
AU - Finel, Moshe
AU - Järvinen, Erkka
PY - 2019/4
Y1 - 2019/4
KW - HUMAN UDP-GLUCURONOSYLTRANSFERASES
KW - CODEINE
KW - 317 Pharmacy
U2 - 10.1111/bcp.13868
DO - 10.1111/bcp.13868
M3 - Letter
VL - 85
SP - 859
EP - 860
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
SN - 0306-5251
IS - 4
ER -